Sign in to view content

Learnings From the Lampalizumab Chroma and Spectri Phase 3 Trials: Effect of Baseline Characteristics on Geographic Atrophy Progression

Carl D. Regillo, MD

Video
Published 2018

Related

Part 1: Implementing Clinical Trials in a Retina Practice: How to Get Started and Recruit Successfully (Part 1 of 3)
Arshad M. Khanani, MD, MA, FASRS
Charles C Wykoff, MD, PhD, FASRS
Carl J Danzig, MD
Nikolas JS London, MD, FACS, FASRS
On Demand Cases, Courses, and Papers
2018
Update From an Ongoing Phase 1b/2 Open-label Clinical Trial Evaluating the Safety and Efficacy of AU-011 for the Treatment of Choroidal Melanoma
Ivana K. Kim, MD
Annual Meeting Talks
2020
Therapies for Diabetic Macular Edema: What’s in the Pipeline?
Peter K. Kaiser, MD FASRS
Updates from the Field
2018

Category: Age-Related Macular Degeneration

See more